Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342364 · ClinicalTrials.gov registry record · NA
Oocyte Survival After Vitrification With Slush Nitrogen Compared With Liquid Nitrogen
A NA study of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT04342364: Completed NA study of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.
NCT04342364 is a NA study of Infertility that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 27 participants, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04342364, a NA study of Infertility, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the use of slush nitrogen results in higher post-thaw survival rates for oocytes compared to conventionally used liquid nitrogen.
Primary Outcome
number of viable oocytes post warming
Conditions Studied
Interventions
- OTHER Vitrification via slush nitrogen
- OTHER Vitrification via liquid nitrogen
Study Locations (1)
New Jersey
- Reproductive Medicine Associates of New Jersey - Basking Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
What the finished NCT04342364 record still lists
NCT04342364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Vitrification via slush nitrogen is the first listed.
NCT04342364 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04342364 about?
NCT04342364 is a clinical study titled "Oocyte Survival After Vitrification With Slush Nitrogen Compared With Liquid Nitrogen". The purpose of this study is to determine if the use of slush nitrogen results in higher post-thaw survival rates for oocytes compared to conventionally used liquid nitrogen.
What is the current status of trial NCT04342364?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2020-04-08. Estimated completion is 2021-07-01.
What conditions does trial NCT04342364 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT04342364?
The interventions under investigation include: Vitrification via slush nitrogen (OTHER), Vitrification via liquid nitrogen (OTHER).
Who is sponsoring clinical trial NCT04342364?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04342364 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04342364's enrollment target sits among peer trials
27 72nd of 74 higher than 3 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
RECRUITING · NA
-
Testicular Tissue Cryopreservation in Children
RECRUITING · NA
-
Sex Selection of Human Spermatozoa
RECRUITING · NA
-
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI